Prepidil Gel
Product Images NDC 0009-3359

7 FDA label images from Pharmacia & Upjohn Company Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Prepidil (NDC 0009-3359). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Prepidil 01)

Chemical Structure (Prepidil 01)
Chemical structure diagram of dinoprostone, the active ingredient in Prepidil vaginal gel 0.5 mg/3 g. The diagram shows the molecular arrangement and bonds of dinoprostone.*
FDA Label Image

Figure (Prepidil 02)

Figure (Prepidil 02)
An illustration showing a disassembled vaginal gel applicator for Prepidil (dinoprostone) .5 mg/3g. The diagram identifies parts labeled as a plunger extension, protective end cap (plunger extension), and shielded catheter, demonstrating how the components fit together for product use.*
FDA Label Image

Logo (Prepidil 03)

FDA Label Image

Principal Display Panel (3 g Syringe Applicator Label)

Principal Display Panel (3 g Syringe Applicator Label)
Label for Prepidil Gel 0.5 mg, dinoprostone cervical gel for endocervical administration. The sterile vaginal gel is distributed by Pharmacia & Upjohn Company LLC and provided in 3-gram syringe applicators. Storage instructions specify refrigeration at 2° to 8°C (36° to 46°F). The label includes dosage and use directions referencing accompanying prescribing information.*
FDA Label Image

Principal Display Panel (3 g Syringe Label)

Principal Display Panel (3 g Syringe Label)
Multiple identical labels for Prepidil Gel 0.5 mg, a dinoprostone cervical gel. Labels include storage instructions to keep refrigerated at 2° to 8°C, with packaging details noting one 3 gram syringe. Distributed by Pharmacia & Upjohn Company LLC, a division of Pfizer Inc. The Pfizer Injectables logo is also visible on each label along with the NDC 0009-3359-01 and a barcode.*
FDA Label Image

Principal Display Panel (3 gram Syringe Carton)

Principal Display Panel (3 gram Syringe Carton)
Prepidil Gel 0.5 mg vaginal gel packaging label for dinoprostone cervical gel by Pharmacia & Upjohn Company LLC. The label highlights it as a sterile product for endocervical administration, supplied in a 1 to 3 gram syringe with two shielded catheters (10 mm and 20 mm tips). The label includes usage instructions, storage conditions (2° to 8°C), and Pfizer branding, with NDC 0009-3359-01 visible.*
FDA Label Image

Principal Display Panel (3 g Syringe Bundle Label)

Principal Display Panel (3 g Syringe Bundle Label)
Label for Prepidil Gel 0.5 mg, containing dinoprostone cervical gel supplied in 5 syringes, each 3 grams. The label displays the NDC numbers 0009-3359-02 and 0009-3359-01, with distribution by Pharmacia & Upjohn Company LLC, a division of Pfizer Inc., New York, NY. The label notes the product is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.